Clearmind Medicine Inc. Stock Canadian Securities Exchange
Equities
CMND
CA1850534027
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.78M 2.44M |
---|---|---|---|---|---|
Net income 2022 | -9M -12.31M | Net income 2023 | -8M -10.94M | EV / Sales 2022 | - |
Net cash position 2022 | 388K 530K | Net cash position 2023 | 5.51M 7.54M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.09
x | P/E ratio 2023 |
-0.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.73% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |